1. MG-132: Fighting Cancer Cells

    Tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is a promising anticancer agent because it induces apoptosis in cancer cells but not in normal cells.
  2. Proteasome Inhibitor MG132 Induces Death Receptor

    Combined treatment with a proteasome inhibitor and tumor necrosis factor–related apoptosis-inducing ligand (TRAIL) is a promising strategy for cancer therapy.

2 Item(s)

To Top